Literature DB >> 22855520

Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous Mycobacteria.

Meng-Rui Lee1, Aristine Cheng, Yu-Tsung Huang, Chia-Ying Liu, Kuei-Pin Chung, Hao-Chien Wang, Sheng-Kai Liang, Chun-Hsing Liao, Chong-Jen Yu, Po-Ren Hsueh.   

Abstract

We evaluated the performance of the DR. TBDR/NTM IVD kit, which was designed to detect Mycobacterium tuberculosis, rifampin-resistant M. tuberculosis, and nontuberculous mycobacteria, for detecting 110 positive and 50 negative cultures in Mycobacterium Growth Indicator Tubes. The accuracy rate of this kit for identification of Mycobacterium species was 95.5% (105/110).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855520      PMCID: PMC3457463          DOI: 10.1128/JCM.01862-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species.

Authors:  C Y Turenne; L Tschetter; J Wolfe; A Kabani
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis.

Authors:  C-C Shu; J-T Wang; J-Y Wang; C-J Yu; L-N Lee
Journal:  Clin Microbiol Infect       Date:  2011-06-01       Impact factor: 8.067

3.  Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration.

Authors:  Meng-Rui Lee; Li-Ta Keng; Chin-Chung Shu; Shih-Wei Lee; Chih-Hsin Lee; Jann-Yuan Wang; Li-Na Lee; Chong-Jen Yu; Pan-Chyr Yang
Journal:  J Infect       Date:  2011-11-12       Impact factor: 6.072

4.  Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus.

Authors:  Sylvia Cardoso Leao; Enrico Tortoli; Jean Paul Euzéby; Maria Jesus Garcia
Journal:  Int J Syst Evol Microbiol       Date:  2010-10-29       Impact factor: 2.747

Review 5.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

6.  Fatal meningitis caused by Mycobacterium nonchromogenicum in a patient with nasopharyngeal carcinoma.

Authors:  Chih-Cheng Lai; Huan-Wen Chen; Wen-Lun Liu; Liang-Wen Ding; Chih-Liang Lin; Gin-Der Lu; Po-Ren Hsueh
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

7.  CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.

Authors:  Meng-Rui Lee; Aristine Cheng; Yi-Chieh Lee; Ching-Yao Yang; Chih-Cheng Lai; Yu-Tsung Huang; Chao-Chi Ho; Hao-Chien Wang; Chong-Jen Yu; Po-Ren Hsueh
Journal:  J Antimicrob Chemother       Date:  2011-10-06       Impact factor: 5.790

8.  Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences.

Authors:  A Roth; M Fischer; M E Hamid; S Michalke; W Ludwig; H Mauch
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 9.  Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections.

Authors:  Jerome A Lindeboom; Lesla E S Bruijnesteijn van Coppenraet; Dick van Soolingen; Jan M Prins; Eduard J Kuijper
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

10.  Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens.

Authors:  Jann-Yuan Wang; Li-Na Lee; Chin-Sheng Chou; Chung-Yi Huang; Shu-Kuan Wang; Hsin-Chih Lai; Po-Ren Hsueh; Kwen-Tay Luh
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more
  4 in total

1.  Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria.

Authors:  Jung-Yien Chien; Tsung-Chain Chang; Wei-Yih Chiu; Chong-Jen Yu; Po-Ren Hsueh
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 2.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

3.  A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis.

Authors:  Ching-Yu Chen; Jui-Yun Weng; Hsin-Hui Huang; Wen-Chun Yen; Yu-Han Tsai; Tsung Chain Cheng; Ruwen Jou
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

4.  Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease.

Authors:  Meng-Rui Lee; Ching-Yao Yang; Kai-Ping Chang; Li-Ta Keng; David Hung-Tsang Yen; Jann-Yuan Wang; Huey-Dong Wu; Li-Na Lee; Chong-Jen Yu
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.